Thursday, November 5, 2020

8:30 am to 8:45 am

Welcome and Opening Remarks
Diane Carter- POHMS President
Linda DeAngelis – NJSOM President

8:45 am to 9:45 am

COVID-19, Elections & Cancer Care – What A Year!!!
Ted Okon - Executive Director
Community Oncology Alliance

9:50 am to 10:50 am

2021 E&M Changes and Documentation Requirements
Michelle Weiss
Weiss Oncology Consulting

• Learn which codes are affected by the changes
• Understand the new E/M Guidelines and how to choose the level of service
• Know when and how the prolonged service codes apply
• Evaluate oncology coding examples

10:50 am to 11:30 am

Break – Please visit our Virtual Exhibit Hall

11:30 am to 12:30 pm

• Mergers and consolidation of Payers, PBMs & SPs – 2 slides
• High deductible health plans & their impact on patients and care
• OOP Costs for Oral anticancer medications
• Medicare Advantage Overview, including growth in enrollment and OOP costs
• Implementation of Step Therapy in Medicare Part B covered drugs
• Spotlight on Oral Oncolytic Adherence

12:30 pm to 1:00 pm

LUNCH BREAK – Don’t forget to visit our Virtual Exhibit Hall and gain more points for our challenge

1:00 pm to 2:00 PM

Overview of HIPAA Developments
Helen Oscislawski, Esq
Managing Partner
Attorneys at Oscislawski LLC

• Review of the HIPAA basics
• Review of HIPAA Breach response, notices and reporting
• Key OCR HIPAA enforcement actions & resolution agreement
• Key HIPAA guidance and FAQs issued by HHS/OCR
• Developments and federal guidance on security, ransomware attacks, telehealth, and use of software Apps
• HIPAA litigation re: patient access rights, fee copy caps and directing copies to third-parties
• Regulatory change to calculating Penalties for HIPAA violations

2:00 pm to 2:30 pm

Break – please visit our Virtual Exhibit Hall

Overview of HIPAA Developments Continued

TBD

CHOC Member Business Meeting
(By invitation only for Active and Associate CHOC members)

Friday, November 6, 2020

POHMS Member Business Meeting
(By invitation only for Active and Associate POHMS Members)

Harassment in the Workplace: How To Avoid Liability
COVID-19 Business Updates
George C. Hlavac, Esq.
Hoffman Hlavac & Easterly
Attorneys at Law

• This presentation will focus on the steps that all medical practices must take to protect against harassment-based
  liability. Issues to be discussed include: the importance of properly drafted harassment policies; mandatory
  employee harassment training; understanding the employer’s duty to prevent harassment in the workplace; and
  taking prompt and appropriate corrective action with respect to inappropriate employee conduct.

Break – please visit our Virtual Exhibit Hall

Pandemic Law
George C. Hlavac, Esq.
Hoffman Hlavac & Easterly
Attorneys at Law

• This presentation will address the employment law issues that all hospitals and medical practices have been struggling
  with during the COVID-19 pandemic, including: furloughs, layoffs, recalls, unemployment compensation,
  discrimination claims, child care leave, ADA and FMLA problems, and many others. The presentation will include a
  15 minute general Q&A to answer pandemic-related employment law questions that attendees may have.

How the Information Blocking Rules Changed HIPAA
Helen Oscislawski, Esq
Managing Partner
Attorneys at Oscislawski LLC

• What constitutes “Information Blocking” (i.e., “interfere with,” “prevent” or “materially discourage”) by
  healthcare Providers, including discussion of specific use case examples
• How to permissibly educate your patients about privacy & security risks without
  engaging in impermissible “interference with” sharing of EHI
• How to implement the “Preventing Harm” exception, and revise your HIPAA Policy
  accordingly
• How to implement the “Privacy” exception, and revise your HIPAA Policy accordingly
• Impact of the “Content & Manner” exception
• Penalties applicable to providers who engage in Info Blocking
• Deadlines for healthcare Provider compliance

Break – please visit our Virtual Exhibit Hall

How the Information Blocking Rules Changed HIPAA – Continued

Conclusion and Closing Remarks